STOCK ALARM
PRO
SA
PRO
News
Screener
Rankings
Themes
Alerts
More
⌘
K
⌘
J
Pro
Sign In
Free Account
Themes
Purple Biotech Ltd.
PPBT
NASDAQ
Loading
Overview
Intelligence
Charts
News
Fundamentals
Financials
Analysis
More
Explore More
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance
Income
Balance
Cash Flow
Annual
Quarterly
3Y
5Y
10Y
All
Revenue
$0
↓100%
Gross Profit
$-186K
↓94798%
Operating Income
$-11M
↑51%
Net Income
$-7M
↓36319%
EBITDA
$-7M
↑65%
EPS Diluted
-44.2
Cost of Revenue
$186K
Gross Margin %
0.0%
R&D Expenses
$8M
SG&A Expenses
$3M
Operating Expenses
$11M
Operating Margin %
0.0%
Interest Expense
$447K
Income Before Tax
$-7M
Income Tax Expense
$0
Net Margin %
0.0%
EPS
-44.2
Shares Out (Diluted)
164.0K
Shares Out (Basic)
164.0K
Total Costs & Expenses
$11M
Interest Income
$260K
EBITDA Margin %
0.0%
Pre-Tax Margin %
0.0%
Other Income/Expenses
$4M
Revenue CAGR (5Y)
—
Margin Trend
declining
Free Cash Flow
($0.0B)
Profitability
Unprofitable
Metric
Dec 20
Dec 21
Dec 22
Dec 23
Dec 24
Revenue
1
0
0
0
0
Gross Profit
1
-0
↓100.0%
-0
↓118.2%
-0
↓63.3%
-0
↓94798.0%
Operating Income
-13
-18
↓35.5%
-23
↓26.0%
-22
↑1.5%
-11
↑50.6%
Net Income
-28
-18
↑34.3%
-22
↓17.9%
-0
↑99.9%
-7
↓36318.5%
EBITDA
-28
-18
↑38.3%
-21
↓22.7%
-20
↑7.5%
-7
↑64.5%
EPS Diluted
-500.00
-200.00
↑60.0%
-240.00
↓20.0%
-180.00
↑25.0%
-44.20
↑75.4%
Show all metrics
← Newer
1 / 2
Older →
Values in millions except EPS · Ratios shown as percentages